CIBC Bancorp USA »

Allogene Therapeutics shares owned by CIBC Bancorp USA

Quarter-by-quarter ownership of Allogene Therapeutics (ALLO) shares owned by CIBC Bancorp USA from 13F filings

Historical chart of CIBC Bancorp USA investment in Allogene Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Allogene Therapeutics held by CIBC Bancorp USA consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Allogene Therapeutics by CIBC Bancorp USA

Quarter filed Position value Share count Share price at filing
2025-09-30 $20k 16k 1.24

More positions owned by CIBC Bancorp USA

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Mastercard Incorporated Cl A (MA)
Ishares Tr U.s. Real Es Etf (IYR)
Alphabet Cap Stk Cl C (GOOG)
JPMorgan Chase & Co. (JPM)
Tesla Motors (TSLA)
Linde SHS (LIN)
Cognizant Technology Solutio Cl A (CTSH)
Berkshire Hathaway Inc Del Cl B New (BRK.B)

View all positions for CIBC Bancorp USA

Top funds holding Allogene Therapeutics

Pfizer
Tpg Gp A
BlackRock
Citadel Advisors
Vanguard Group
PRIMECAP Management Company
Woodline Partners
Frazier Life Sciences Management
Geode Capital Management
UBS Group
Millennium Management
Two Sigma Investments
Patient Square Capital
Wildcat Capital Management
Renaissance Technologies

View all funds holding Allogene Therapeutics